Cosmos Health | 8-K: Current report
04:37
Cosmos Health | 8-K: Entered Into A Rights Agreement
Apr 26 05:27
Cosmos Health | 8-K: Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
Apr 20 05:05
Cosmos Health | NT 10-K: Others
Apr 3 04:37
Cosmos Health | 8-K: Cosmos Health Receives a Non-Compliance Letter from Nasdaq and Company Defines Policies and Procedures for Related Party Transactions
Mar 23 04:30
Cosmos Health | 424B3: Prospectus
Mar 8 05:37
Cosmos Health | 424B3: Prospectus
Mar 1 05:41
Cosmos Health | 4: Statement of changes in beneficial ownership of securities-Officer Siokas Grigorios
Feb 21 23:26
Cosmos Health | 424B3: Prospectus
Feb 16 05:11
Cosmos Health | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Feb 15 04:38
Cosmos Health | EFFECT: Others
Feb 9 19:04
Cosmos Health | CORRESP: CORRESP
Feb 7 01:03
Cosmos Health | UPLOAD: Others
Feb 6 01:03
Cosmos Health | S-3: Registration statement for specified transactions by certain issuers
Jan 30 06:20
Cosmos Health | 8-K: Cosmos Health Announces Acquisition of Licenses and Rights to 10 Generic Drugs for €3.2 Million
Jan 22 13:00
Cosmos Health | 8-K/A: Cosmos Health Set for Substantial Growth from Acquisitions Completed in 2023 and Entered into a Warrant Exchange Agreement (Amendment)
Dec 29, 2023 13:00
Cosmos Health | 8-K: Cosmos Health Set for Substantial Growth from Acquisitions Completed in 2023 and Entered into a Warrant Exchange Agreement
Dec 29, 2023 13:00
Cosmos Health | 4: Statement of changes in beneficial ownership of securities-Director Aslidis Anastasios
Dec 23, 2023 05:05
Cosmos Health | 8-K: Cosmos Health Board of Directors Adopted a Executive Compensation Clawback Policy
Nov 29, 2023 05:05
Cosmos Health | 8-K: Cosmos Health Reports Q3 2023 Results
Nov 22, 2023 22:30
No Data
No Data